Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

导出 LinkOut

翻译打印收藏纠错

作者： Hiva,Azizi ^[1] ; Jason P,Knapp ^[2] ; Yue,Li ^[3] ; Alice,Berger ^[3] ; Marc-Alexandre,Lafrance ^[1] ; Jannie,Pedersen ^[1] ; Marc-Antoine,de la Vega ^[1] ; Trina,Racine ^[1] ; Chil-Yong,Kang ^[4] ; Jamie F S,Mann ^[1] ; Jimmy D,Dikeakos ^[5] ; Gary,Kobinger ^[3] ; Eric J,Arts ^[6]

作者单位： Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada. ^[1] Human Health Therapeutics, National Research Council Canada, Ottawa, ON K1N 5A2, Canada. ^[2] Department of Microbiology and Immunology, Western University, London, ON N6A 3K7, Canada. ^[3] Galveston National Laboratory, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA. ^[4] Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada. ^[5] Bristol Veterinary School, University of Bristol, Langford House, Langford, BS40 5DU Bristol, UK. ^[6]

关键词 Ebola virus glycoprotein HIV-1 Envelope glycoprotein human immunodeficiency virus type 1 (HIV-1)vesicular stomatitis virus (VSV) vector

DOI 10.3390/vaccines11050977

PMID 37243081

发布时间 2024-06-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vaccines

2023年11卷5期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Vaccines

相似文献

Vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Vaccines

相似文献

Vaccines

相关期刊

检索历史清除